INSIGHTS ON DRUG DEVELOPMENT
-
The Continuing Challenge Of Drug-Induced Liver Injury
Recent liver safety concerns highlight the limits of conventional preclinical testing. Human-relevant models could help researchers detect drug-induced liver injury earlier and reduce costly setbacks.
-
AAV Downstream Challenges: Expert Insights
Gain expert insight into the complexities of AAV purification to learn how industry leaders tackle downstream challenges, optimize workflows, and drive innovation in scalable, efficient gene therapy manufacturing solutions.
-
Identification Of GLP-1 Analog Oligomeric States Using SEC-MALS
Discover how SEC-MALS enables precise characterization of GLP-1a therapeutics to ensure formulation integrity and enhance safety, efficacy, and regulatory confidence.
-
EMA Support For SMEs Through Scientific Advice And Early Dialogue
Discover how early engagement with European regulators helps smaller drug developers reduce uncertainty, clarify requirements, and de‑risk innovative programs through early dialogue.
-
Streamline Your Workflow With An Innovative Fixed-Bed System11/4/2025
Discover how an innovative fixed-bed system streamlines workflows and supports consistent, high-yield manufacturing across a range of applications.
-
Cell Culture Automation Of The 3D Cancer Spheroid Assay3/24/2025
Discover how automated 3D cell culture methods enhance efficiency and consistency in high-throughput drug screening to accelerate the discovery of new anti-cancer therapies.
-
Innovative Strategies For Residual DNA And Viral Titre Quantitation5/22/2025
Discover how digital PCR improves the accuracy of residual host cell DNA and viral titre quantification in biotherapeutic manufacturing to enhance product quality, safety, and regulatory compliance.
-
UPLC-MS/MS Determination Of GLP-1 Analogue7/17/2025
Discover a robust, evaporation-free method for analyzing liraglutide in human plasma using LC-MS/MS to ensure high sensitivity, reproducibility, and improved analyte recovery.
-
Characterizing Protein Stability By DSC9/24/2026
Discover how differential scanning calorimetry quantifies the thermodynamic forces behind protein folding and stability, providing valuable insight for protein engineering and therapeutic formulation.
DRUG DEVELOPMENT SOLUTIONS
-
Learn how harnessing a CDMO’s extensive knowledge and skills in dealing with controlled substances can help you advance your innovative psychedelic therapeutic safely and efficiently.
-
One MS Software for All Your Mass Spectral Data Analysis and Management
ACD/MS Workbook Suite is an all-in-one package for MS data handling.
- Process MS, LC/MS, and GC/MS data acquired with instruments from any major vendor
- Auto-annotate peaks and associate them with compound structures
- Identify unknowns by deconvoluting spectra and searching databases for spectral matches
- Create easily shareable and searchable spectral databases
-
Partner with a trusted, globally proven CDMO whose world-class, rapidly scalable facilities and unwavering commitment to quality help accelerate patient access to life-saving biologics.
-
Curia’s DMPK scientists deliver expert solutions for your drug discovery programs. Providing bioanalytical methods development, in vitro ADMET testing and in vivo PK and PD services that span all stages of drug discovery up to candidate selection.
-
The Waters Chemistry Technical Service team that can assist with recommending products for development methods, guidance in optimizing conditions for established methods, to troubleshooting any deviation from expected analytical outcomes.